Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
7/13/2021
Biogen Licenses Certain Rights of Anticancer Orelabrutinib from InnoCa...
7/13/2021
Kintor Pharma Greenlighted for Pyrilutamide's Phase II Trial in the US
7/13/2021
Everest Medicines and Tencent Enters Strategic Commercial Partnership
7/13/2021
Takeda's NSCLC Drug Mobocertinib NDA Accepted with Priority Review in ...
7/13/2021
CDE Seeks Comments on Draft ICH Guidelines S12
7/13/2021
PharmaDJ's China Market Approval Tracker: May 2021
7/13/2021
Patent Linkage System in China: Judicial Provisions and Administrative...
7/13/2021
Nikkei: Avigan Maker Fujifilm Faces Patent Risk from China's AMMS
7/13/2021
Seizing Opportunities in China's Healthcare Sector
7/12/2021
Eli Lilly and Tencent Enter Digital MedPharm Partnership in China
7/12/2021
Gilead Sciencesand JD Health Enter Strategic Partnership for Digital H...
7/11/2021
Shanghai I-Mab Enters Two New Oncology Partnerships
7/11/2021
Biocytogen/Eucure Biopharma's CTLA-4 and CD40 mAbs Approved for Phase ...
7/9/2021
MOFCOM Plans to Beef Up Scrutinization of Foreign Investment
7/9/2021
Takeda's NDA for Mobocertinib (TAK-788) Accepted in China as a Treatme...
7/9/2021
Recent Executive Moves
7/9/2021
Innovent's NDA for FGFR1/2/3 Inhibitor (Pemigatinib) Accepted in China...
7/9/2021
Schott Inaugurates New Glass Tubing Plant in China
7/8/2021
Parexel Expands A/P Capability with New China Depot Planned
7/8/2021
CDE Solicits Comments on the Technical Guidelines for Clinical Pharmac...
7/8/2021
CDE Solicits Comments on the Technical Guidelines for Pharmacokinetic ...
7/8/2021
CDE Solicits Comments on the Guidelines for Clinical Research of Late ...
7/8/2021
CDE Solicits Comments on the Technical Guidelines for Writing Safety R...
7/8/2021
Sparx Therapeutics to Build Its First ADC Production Facility in Yangz...
7/8/2021
BeiGene/Amgen Wins Chinese Approval of KYPROLIS (Crfilzomib) for r/r M...
7/8/2021
China Passes Data Security Law to Take Effect in Less Than Two Months
7/8/2021
Revision of China's Anti-Monopoly Law to Close "Loopholes" in Anti-car...
7/8/2021
Ex-Genentech Staffers Plead Guilty To Trade Secrets Theft as DOJ Targe...
7/8/2021
Is China's Drug Regulator Suddenly Raising the Bar on Cancer Med R&D? ...
7/7/2021
Further Updates on Patent Linkage and Patent Term Extension in China
Page:
194
/
789
Total number of articles:
23668
:
[First]
[<<]
[192]
[193]
[194]
[195]
[196]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit